Drug intelligence / Profile preview

JuanBiQiangGu + methotrexate

Development stage
Unknown
Lead developer
Shanghai University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

JuanBiQiangGu + methotrexate is a combination therapy used primarily for treating rheumatoid arthritis. This combination consists of JuanBiQiangGu Granules (JBQG), a traditional Chinese medicine formula, administered alongside methotrexate, which is a conventional disease-modifying antirheumatic drug (DMARD). ## Composition and Classification The combination therapy pairs JuanBiQiangGu Granules, taken three times daily (8 mg tid), with weekly methotrexate (typically 7.5 mg qw)[2]. This represents a form of combination therapy where a traditional Chinese medicine is used alongside a conventional Western pharmaceutical. ## Therapeutic Use and Effectiveness Clinical research has demonstrated that JuanBiQiangGu Granules combined with methotrexate can effectively: - Alleviate joint inflammation in rheumatoid arthritis patients - Reduce the incidence of adverse reactions to methotrexate - Provide good safety profile for patients[1][2] A randomized controlled trial evaluated this combination against methotrexate monotherapy over a 12-week treatment period. The study measured various clinical indices including DAS28-ESR (Disease Activity Score), HAQ-DI (Health Assessment Questionnaire Disability Index), and Sharp scores, along with inflammatory markers such as CRP, ESR, TNF-α, IL-1β, IL-6, IL-17, and INF-γ[2]. ## Mechanism of Action While the specific mechanism of JuanBiQiangGu Granules is not fully detailed in the search results, methotrexate is known to be an immunosuppressant that serves as an anchor drug among disease-modifying antirheumatic agents[3]. The combination appears to work synergistically to control inflammation and reduce joint damage in rheumatoid arthritis. ## Development Status This combination has undergone clinical trials, including a randomized controlled trial registered with the identifier ChiCTR2100046373[2]. The research was conducted by institutions including Shanghai University of Traditional Chinese Medicine and Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine[2]. ## Safety Profile The combination therapy has demonstrated a favorable safety profile, with JuanBiQiangGu Granules specifically noted to reduce the incidence of adverse reactions associated with methotrexate[1][2]. This is significant as methotrexate can cause various side effects, including liver toxicity when combined with certain other medications[7].

Other names
JuanBiQiangGu Granules + methotrexate
02

Targets

HMGB1 (High mobility group protein B1)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on JuanBiQiangGu + methotrexate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JuanBiQiangGu + methotrexate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call